Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction

This publication has 15 references indexed in Scilit:

• A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
  Journal of the American College of Cardiology, 1994
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.
  Circulation, 1992
• Plasma levels of plasminogen activator inhibitor type 1, beta- thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase
  Blood, 1991
• Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
  Circulation, 1989
• Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity
  Blood, 1988
• Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis
  Journal of the American College of Cardiology, 1987
• Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis
  Journal of the American College of Cardiology, 1986
• Fibrinopeptide A: a marker of acute coronary thrombosis.
  Circulation, 1985
• Rapid radioimmunoassay of human fibrinopeptide A — Removal of cross-reacting fibrinogen with bentonite
  Thrombosis Research, 1980